Gotham Therapeutics launched in New York with a $54 million Series A financing. The round was co-led by founding investor Versant Ventures, Forbion and S.R. One. The investment syndicate included Celgene Corporation and Alexandria Venture Investments.
{iframe}https://www.biospace.com/article/gotham-therapeutics-launches-in-new-york-city-with-54-million-series-a-financing/{/iframe}